Fosun Pharmaceutical (02196.HK) announced that on April 9, 2024, the company's holding subsidiary Shanghai Fuhong Hanlin Biotechnology Co., Ltd. (“Fuhong Hanlin”) and its holding subsidiaries Shanghai Fuhong Hanlin Biopharmaceutical Co., Ltd. (“Hanlin Pharmaceuticals”) and Shanghai Fuhong Hanlin Biomedical Co., Ltd. (“Hanlin Pharmaceuticals”) signed a “Credit Agreement” with China Merchants Bank Co., Ltd. Shanghai Branch (“China Merchants Bank”). Is it OK to jointly apply for principal amount from China Merchants Bank A shared credit limit of more than RMB 200 million (the credit applicant and the credit sharing applicant's balance of debt that had been raised with China Merchants Bank before the agreement was signed and occupied by the credit line). The credit period was from April 10, 2024 to April 9, 2025 (including the first and last two days). On the same day, Fuhong Hanlin issued a “Maximum Irrevocable Guarantee” (hereinafter referred to as “Guarantee Contract 1”) to China Merchants Bank. Fuhong Hanlin provided the maximum amount of joint liability guarantees for Hanlin Pharmaceutical and Hanlin Pharmaceutical's application to China Merchants Bank within the above amounts, not exceeding the equivalent amount of RMB 100 million and RMB 50 million for debts under shared credit lines of RMB 100 million and RMB 50 million, respectively.